Home > Riviste > Minerva Ginecologica > Fascicoli precedenti > Minerva Ginecologica 2019 April;71(2) > Minerva Ginecologica 2019 April;71(2):97-112

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW  UPDATES ON MATERNAL FETAL MEDICINE 

Minerva Ginecologica 2019 April;71(2):97-112

DOI: 10.23736/S0026-4784.18.04334-4

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Fetal anemia

Pedro S. ARGOTI , Giancarlo MARI

Department of Obstetrics and Gynecology, Health Sciences Center, University of Tennessee, Memphis, TN, USA



The diagnosis and management of fetal anemia has been at the forefront of advances in the fields of fetal physiology, immunology, fetal imaging, and fetal therapy among others. Alloimmunization and parvovirus infection are the leading cause of fetal anemia in the United States. The middle cerebral artery peak systolic velocity (MCA-PSV) diagnoses fetal anemia. Its discovery is considered one of the most important achievements in fetal medicine. Accumulation of experience in recent years as well as refinement of surgical techniques have led to safer invasive procedures. It is expected that long term follow-up of affected pregnancies, continues to reflect all these improvements in care. It is also expected that treatment of other less common causes of fetal anemia becomes more frequently reported and that the management principles of fetal anemia are successfully applied to other fetal pathologies.


KEY WORDS: Anemia - Middle cerebral artery - Fetal erythroblastosis - Parvovirus - Intrauterine blood transfusion

inizio pagina